Organization Overview
Alternative names
fludeoxyglucose f-18 (2016)
abemaciclib (verzenio) (4 trials)
bupivacaine (Exparel) (2 trials)
docetaxel (taxotere) (3 trials)
ibrutinib (imbruvica) (6 trials)
methadone (methadose) (1 trial)
89zr-dfo-daratumumab (1 trial)
abiraterone (zytiga) (2 trials)
acalabrutinib (calquence) (1 trial)
acetaminophen (tylenol) (2 trials)
acetylcysteine (mucomyst) (2 trials)
Afamitresgene autoleucel (1 trial)
allogeneic cord blood (3 trials)
allogeneic t cell progenitors, cultured ex-vivo (1 trial)
aminolevulinic acid (levulan) (1 trial)
amivantamab-vmjw (Rybrevant) (2 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (6 trials)
apalutamide (erleada) (1 trial)
asciminib (Scemblix) (1 trial)
atezolizumab (Tecentriq) (4 trials)
autologous cd34+ cells transduced withpsrs11.efs.il2rg.pre (1 trial)
avelumab (bavencio) (5 trials)
azacitidine (vidaza) (2 trials)
bacille calmette-guerin (1 trial)
bendamustine (treanda) (2 trials)
benralizumab (fasenra) (2 trials)
bevacizumab (avastin) (4 trials)
binimetinib (mektovi) (1 trial)
blinatumomab (blincyto) (1 trial)
bortezomib (velcade) (3 trials)
brentuximab vedotin (adcetris) (1 trial)
cabozantinib (cometriq) (3 trials)
canagliflozin (invokana) (1 trial)
canakinumab (ilaris) (1 trial)
capecitabine (xeloda) (5 trials)
carfilzomib (kyprolis) (4 trials)
cedazuridine (Inqovi) (1 trial)
cemiplimab (libtayo) (2 trials)
certolizumab pegol (cimzia) (1 trial)
clofarabine (clolar) (3 trials)
colesevelam (welchol) (1 trial)
copanlisib (aliqopa) (3 trials)
crizotinib (xalkori) (1 trial)
cyclophosphamide (cytoxan) (12 trials)
cyclosporine (sandimmune) (2 trials)
dabrafenib (tafinlar) (2 trials)
dactinomycin (cosmegen) (1 trial)
daratumumab (darzalex) (10 trials)
dasatinib (sprycel) (2 trials)
diphenhydramine (benadryl) (1 trial)
dostarlimab (Jemperli) (2 trials)
doxorubicin (Doxil) (4 trials)
durvalumab (imfinzi) (8 trials)
elotuzumab (empliciti) (1 trial)
emapalumab-lzsg (gamifant) (1 trial)
encorafenib (braftovi) (1 trial)
enfortumab vedotin (Padcev) (2 trials)
entrectinib (Rozlytrek) (1 trial)
enzalutamide (xtandi) (2 trials)
erdafitinib (Balversa) (1 trial)
etoposide (vepesid) (4 trials)
fam-trastuzumab deruxtecan-nxki (Enhertu) (1 trial)
Filgrastim (neupogen) (5 trials)
fludarabine (fludara) (10 trials)
fluorouracil (efudex) (8 trials)
fulvestrant (faslodex) (7 trials)
gemcitabine (gemzar) (11 trials)
glipizide (glucotrol) (1 trial)
human fecal microbiota (Reybota) (2 trials)
ipilimumab (yervoy) (7 trials)
irinotecan (Camptosar) (8 trials)
Isatuximab (Sarclisa) (1 trial)
ivosidenib (tibsovo) (2 trials)
lenalidomide (revlimid) (10 trials)
lenvatinib (lenvima) (5 trials)
letermovir (prevymis) (1 trial)
liothyronine (cytomel) (1 trial)
lorlatinib (lorbrena) (1 trial)
melphalan (alkeran) (6 trials)
mifepristone (mifeprex) (1 trial)
montelukast (singulair) (1 trial)
mosunetuzumab (Lunsumio) (1 trial)
mycophenolate (CellCept) (3 trials)
naxitamab (Danyelza) (2 trials)
necitumumab (portrazza) (1 trial)
neratinib maleate (nerlynx) (1 trial)
nivolumab (opdivo) (22 trials)
obinutuzumab (gazyva) (4 trials)
olaparib (lynparza) (8 trials)
oxaliplatin (eloxatin) (6 trials)
palbociclib (ibrance) (2 trials)
pancrelipase (creon) (1 trial)
panitumumab (vectibix) (1 trial)
pembrolizumab (keytruda) (25 trials)
potassium iodide (thyro-block) (1 trial)
prednisone (meticorten) (4 trials)
procarbazine (matulane) (1 trial)
ramucirumab (cyramza) (1 trial)
regorafenib (stivarga) (2 trials)
relatlimab (Opdualag) (1 trial)
romiplostim (nplate) (3 trials)
rucaparib (rubraca) (3 trials)
ruxolitinib (jakafi) (3 trials)
sargramostim (leukine) (3 trials)
siltuximab (sylvant) (1 trial)
sucralfate (carafate) (1 trial)
tacrolimus (prograf) (1 trial)
tafasitamab (Monjuvi) (1 trial)
talazoparib (talzenna) (3 trials)
Talquetamab (Talvey) (1 trial)
temozolomide (temodar) (6 trials)
tisagenlecleucel (Kymriah) (1 trial)
tocilizumab (actemra) (2 trials)
trametinib (mekinist) (3 trials)
trastuzumab (herceptin) (3 trials)
tremelimumab (Imjudo) (1 trial)
triamcinolone (kenalog) (2 trials)
valemetostat (Ezharmia) (1 trial)
vemurafenib (zelboraf) (2 trials)
venetoclax (venclexta) (6 trials)
vericiguat (Verquvo) (1 trial)
vincristine (oncovin) (4 trials)
vinorelbine (navelbine) (1 trial)
131i-lipiodol (Lipiodol) (1 trial)
18 F-Fluoro-5α-Dihydrotestosterone (1 trial)
89zr-dfo-crgdy-peg-cy5-c' (1 trial)
adclec.syn1 car t cells (1 trial)
amino acids (Freamine) (1 trial)
autologous cd34+ cells (1 trial)
capivasertib (Truqap) (1 trial)
cd371-ysnvz-il18 car t cells (1 trial)
dacomitinib (vizimpro) (2 trials)
deferoxamine (desferal) (1 trial)
duvelisib (copiktra) (1 trial)
enasidenib (idhifa) (2 trials)
Ga 68 PSMA-11 (Illuccix) (1 trial)
gadobutrol (gadavist) (1 trial)
levothyroxine (Synthroid) (1 trial)
lutetium (177Lu) vipivotide tetraxetan (Pluvicto) (1 trial)
lutetium dotatate lu-177 (Lutathera) (1 trial)
mitomycin (mutamycin) (1 trial)
nirogacestat (Ogsiveo) (1 trial)
Adenocarcinoma (Phase 2)
Adenocarcinoma, Clear Cell (Phase 2)
Adenocarcinoma, Follicular (Phase 2)
Adenoma, Islet Cell (Phase 1)
Adenoma, Oxyphilic (Phase 2)
Adenomyoepithelioma (Phase 2)
Alzheimer Disease (Phase 1)
Amyloidosis (Phase 2)
Anemia (Phase 2)
Anemia, Aplastic (Phase 1)
Astrocytoma (Phase 1)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Burkitt Lymphoma (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Basal Cell (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Carcinosarcoma (Phase 2)
Cholangiocarcinoma (Phase 2)
Chondrosarcoma (Phase 2)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 2)
Cytomegalovirus Infections (Phase 2)
Desmoplastic Small Round Cell Tumor (Phase 2)
Diarrhea (Phase 2)
Disease (Phase 2)
Endometrial Neoplasms (Phase 2)
Ependymoma (Phase 1)
Esophageal Neoplasms (Phase 2)
Fanconi Anemia (Phase 2)
Fanconi Syndrome (Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 1)
Graft vs Host Disease (Phase 2)
Head and Neck Neoplasms (Phase 1)
Hematologic Diseases (Phase 2)
Hematologic Neoplasms (Phase 2)
Hemoglobinopathies (Phase 2)
Histiocytoma, Malignant Fibrous (Phase 2)
Hodgkin Disease (Phase 2)
Hypersensitivity (Phase 2)
Immunoglobulin Light-chain Amyloidosis (Phase 2)
Infections (Phase 2)
Kidney Neoplasms (Phase 2)
Leiomyosarcoma (Phase 2)
Leukemia (Phase 2)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Liposarcoma (Phase 2)
Liver Diseases (Phase 2)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 3)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 2)
Lymphomatoid Papulosis (Phase 2)
Lymphopenia (Phase 2)
Medulloblastoma (Phase 1)
Melanoma (Phase 2)
Meningeal Carcinomatosis (Phase 1)
Mesothelioma (Phase 2)
Metabolic Diseases (Phase 2)
Mixed Tumor, Mullerian (Phase 2)
Multiple Myeloma (Phase 2)
Mycoses (Phase 2)
Mycosis Fungoides (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Basal Cell (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Neoplasms, Second Primary (Phase 2)
Neoplasms, Squamous Cell (Phase 1)
Neurilemmoma (Phase 2)
Neuroblastoma (Phase 2)
Neuroendocrine Tumors (Phase 4)
Neurofibroma (Phase 2)
Neurofibromatoses (Phase 2)
Neurofibromatosis 1 (Phase 2)
Neurofibromatosis 2 (Phase 2)
Neuroma, Acoustic (Phase 2)
Osteosarcoma (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Diseases (Phase 3)
Pancreatic Intraductal Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 3)
Pancytopenia (Phase 2)
Paranasal Sinus Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 1)
Philadelphia Chromosome (Phase 2)
Pituitary Diseases (Phase 2)
Pituitary Neoplasms (Phase 2)
Plasmacytoma (Phase 2)
Primary Myelofibrosis (Phase 2)
Prostatic Neoplasms (Phase 3)
Rectal Neoplasms (Phase 2)
Respiratory Insufficiency (Phase 2)
Retinal Diseases (Phase 2)
Rhabdomyosarcoma (Phase 2)
Salivary Gland Neoplasms (Phase 2)
Sarcoma (Phase 2)
Sarcoma, Alveolar Soft Part (Phase 2)
Sarcoma, Endometrial Stromal (Phase 2)
Sezary Syndrome (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Smoldering Multiple Myeloma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Stomach Neoplasms (Phase 2)
Syndrome (Phase 2)
Thrombocytopenia (Phase 2)
Thyroid Cancer, Papillary (Phase 2)
Thyroid Carcinoma, Anaplastic (Phase 2)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Uterine Neoplasms (Phase 2)
Uveal Neoplasms (Phase 1)
Waldenstrom Macroglobulinemia (Phase 1)
Wilms Tumor (Phase 1)
